The microsurgery robot market is predicted to play “key role” in advanced coronavirus and cancer treatments, according to research by Global Market Insights.
The US microsurgery robot market accounted for $355.1 million in 2017, owing to increasing incidence of cardiovascular, neurovascular, oncology and other chronic diseases.
The increasing prevalence of chronic disease will favor industry growth in the region. Favorable healthcare and reimbursement policies coupled with adoption of technologically advanced microsurgery robots will promote revenue generation in the future. [Read more…] about Microsurgery robot market to play ‘key role’ in advanced cardiovascular diseases and cancer treatments